Astoriom
Generated 5/10/2026
Executive Summary
Astoriom is a Dublin-based digital health and AI/ML company that provides global expertise in ICH stability storage, biorepository, and equipment servicing within cGMP facilities. Founded in 2020, the company focuses on worry-free storage solutions for the pharmaceutical and biotechnology sectors, ensuring compliance with international standards. By leveraging advanced technologies, Astoriom aims to enhance the reliability and efficiency of storage and equipment management for critical research and development materials. The company's strategic location in Ireland, a hub for life sciences, positions it well to serve a growing client base seeking high-quality, regulated storage services. With a dedicated team of experts, Astoriom is poised to capitalize on the increasing demand for specialized storage and biorepository solutions in the global pharmaceutical industry.
Upcoming Catalysts (preview)
- Q3 2026Expansion of cGMP facility capacity in Dublin70% success
- Q4 2026Strategic partnership with a major pharmaceutical company50% success
- 2027Launch of AI-driven predictive maintenance for equipment servicing60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)